Nisha Rathode (Editor)

Alexander von Gabain

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Name
  
Alexander Gabain


Alexander von Gabain p59046typo3serverinfotypo3temppicsd2174d5d88jpg

Biovision 2014 alexander von gabain


'Alexander von Gabain', PhD, is known for his work in Molecular microbiology and vaccine development. He is also an entrepreneur in the biotech industry. His contributions to basic and translational biomedical research are documented by a large number of publications, book chapters, edition of books, patents

Contents

Biography

von Gabain obtained his PhD. in Genetics at the University of Heidelberg and held a post-doctorate position at the Stanford University from 1979 to 1982.

In the 1980s and 1990s, he was Professor at the University of UmeƄ and at the Karolinska Institute in Stockholm, Sweden, as well as an advisor to pharmaceutical and biotech companies.

Intercell

von Gabain co-founded Intercell AG in 1998, led the company until it was successfully floated on the Vienna Stock Exchange in 2005 and continued as Chief Scientific Officer in the Executive Board until 2009. In 2011, he was appointed to serve the Company as member of the Supervisory Board (www.intercell.com).

During his executive years, the firm succeeded to globally register and launch a novel vaccine against Japanese Encephalitis. Additionally, he has accompanied further biotech enterprises in various functions. His entrepreneurial and scientific knowledge in the innovation arena has been recruited into organisations fostering entrepreneurial innovation; in 2003 into the Technology Seed Fond of the University and Technical University in Vienna, Inits (www.inits.at), of which he is chairing the supervisory Board, and in 2008 into the Governing Board of the European Institute of Innovation and Technology (EIT). In 2011, he was elected to become the Chairman of the EIT Governing Board (www.eit.europa.eu).

From 1992 to 1998, he was chair of Microbiology of the University of Vienna and engaged in building the public private partnership of the Campus Vienna Biocenter at IMP.

He has academic appointments as professor at the Max F. Perutz Laboratories of the University of Vienna (www.mfpl.ac.at) and foreign adjunct professor at the Karolinska Institute in Stockholm, and he is a member of the Swedish Royal Academy of Engineering Science.

References

Alexander von Gabain Wikipedia